IHS Chemical Week

World News and Views :: Projects

Wacker Builds Biologics

12:43 PM MDT | April 3, 2009

Wacker Chemie says it will develop its biologics operation at Jena, Germany as part of a strategy to expand the company’s fine chemicals business. The Jena facility specializes in using microbial systems, mainly E-coli, for the production of biologics. Wacker is investing about €15 million ($20 million) to expand the operation including a recently opened new process-development unit for pharmaceutical proteins. The company also will double the size of its Jena GMP production facility for biopharmaceuticals by year-end. Wacker has pulled out of contract...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa